GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS
Clinical trials for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer patients with abdominal spread: experimental drug combo enters trial
Disease control Not yet recruitingThis phase 2 trial is testing whether adding an experimental immunotherapy drug called SHR-1701 to standard chemotherapy can help people with stomach cancer that has spread to the lining of the abdomen. The study will enroll 60 adults and compare two different chemotherapy combin…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy aims to shrink stomach cancer spread
Disease control Not yet recruitingThis study tests a treatment plan for people with stomach cancer that has spread to the lining of the abdomen. The plan combines heated chemotherapy directly in the abdomen (HIPEC), standard chemotherapy, and an immunotherapy drug called tislelizumab. The goal is to see if this c…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WITH PERITONEAL METASTASIS
Phase: PHASE2 • Sponsor: Hebei Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC